Google DeepMind’s Spinoff Company ‘Very Close’ to Human Trials for Its AI-Designed Drugs
Google DeepMind’s drug-discovery spinoff, Isomorphic Labs, is on the verge of starting human trials for its AI-designed drugs. Aiming to revolutionise the pharmaceutical landscape, the company leverages AI, particularly the…
